Battered after a spectacular failure with its Alzheimer’s drug candidate, Neurotrope Biosciences is being absorbed by a privately-held company that makes an erectile dysfunction (ED) treatment.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,